The effect of 3,4‐methylenedioxymethamphetamine (MDMA, ?ecstasy?) and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus
British Journal of Pharmacology – February 01, 2002
Source: OpenAlex
Summary
MDMA, commonly known as ecstasy, significantly stimulates the release of vasopressin and oxytocin, two crucial neuropeptides. In experiments with male Wistar rats (n=5-8), HMMA (4-hydroxy-3-methoxymethamphetamine) was found to be the most potent, increasing vasopressin release from a baseline ratio of 1.1 to 2.7 at 10 nM. MDMA also elevated vasopressin levels, showing a ratio increase from 1.5 at the same concentration. These findings highlight the complex interactions between MDMA and neuroendocrine regulation, with implications for understanding its effects on behavior and physiology.
Abstract
Methylenedioxymethamphetamine (MDMA, “ecstasy”), widely used as a recreational drug, can produce hyponatraemia. The possibility that this could result from stimulation of vasopressin by MDMA or one of its metabolites has been investigated in vitro . Release of both oxytocin and vasopressin from isolated hypothalami obtained from male Wistar rats was determined under basal conditions and following potassium (40 m M ) stimulation. The results were compared with those obtained for basal and stimulated release in the presence of MDMA or metabolites in the dose range 1 μ M to 100 p M ( n =5 – 8) using Student's t ‐test with Dunnett's correction for multiple comparisons. All compounds tested affected neurohypophysial hormone release, HMMA (4‐hydroxy‐3‐methoxymethamphetamine) and DHA (3,4‐dihydroxyamphetamine) being more active than MDMA, and DHMA (3,4‐dihydroxymethamphetamine) being the least active. The effect on vasopressin release was greater than that on oxytocin. In the presence of HMMA the ratio test:control for basal release increased for vasopressin from 1.1±0.16 to 2.7±0.44 (s.e.m., P <0.05) at 10 n M and for oxytocin from 1.0±0.05 to 1.6±0.12 in the same hypothalami. For MDMA the ratio increased to 1.5±0.27 for vasopressin and to 1.28±0.04 for oxytocin for 10 n M . MDMA and its metabolites can stimulate both oxytocin and vasopressin release in vitro , the response being dose dependent for each drug with HMMA being the most potent. British Journal of Pharmacology (2002) 135 , 649–656; doi: 10.1038/sj.bjp.0704502